APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glucagon Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Glucagon Drug Market Outlook and Growth Opportunities 2026

2 January 2026196 pages

Choose your research edition.

Industry ResearchGlucagon Drug Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Glucagon Drug Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Glucagon Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glucagon Drug Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Glucagon Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Glucagon Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Glucagon Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Glucagon Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glucagon Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Glucagon Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Glucagon Drug market include Eli Lilly, Fresenius Kabi, Torrent Labs and Novo Nordisk, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Glucagon Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Glucagon Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Glucagon Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glucagon Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Glucagon Drug Segment by Company

Eli Lilly

Fresenius Kabi

Torrent Labs

Novo Nordisk

Glucagon Drug Segment by Type

Inject Glucagon

Nasal Glucagon

Glucagon Drug Segment by Application

Cardiogenic Shock

General Use

Emergency Kits

Diagnostic & Motility

Others

Glucagon Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Glucagon Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Glucagon Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Glucagon Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Glucagon Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucagon Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glucagon Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucagon Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Glucagon Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Glucagon Drug industry.

Chapter 3: Detailed analysis of Glucagon Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Glucagon Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Glucagon Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Glucagon Drug Industry Trends Table 2. Glucagon Drug Industry Drivers Table 3. Glucagon Drug Industry Opportunities and Challenges Table 4. Glucagon Drug Industry Restraints Table 5. Global Glucagon Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Glucagon Drug Revenue Share by Company (2021-2026) Table 7. Global Glucagon Drug Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Glucagon Drug Sales Volume Share by Company (2021-2026) Table 9. Global Glucagon Drug Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Glucagon Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Glucagon Drug Key Company Manufacturing Base & Headquarters Table 12. Global Glucagon Drug Company, Product Type & Application Table 13. Global Glucagon Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Glucagon Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Inject Glucagon Table 18. Significant Companies of Nasal Glucagon Table 19. Global Glucagon Drug Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Glucagon Drug Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Glucagon Drug Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Glucagon Drug Sales Volume Share by Type (2021-2026) Table 23. Global Glucagon Drug Sales Volume Share by Type (2027-2032) Table 24. Global Glucagon Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Glucagon Drug Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Glucagon Drug Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Glucagon Drug Sales Value Share by Type (2021-2026) Table 28. Global Glucagon Drug Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Cardiogenic Shock Table 30. Significant Companies of General Use Table 31. Significant Companies of Emergency Kits Table 32. Significant Companies of Diagnostic & Motility Table 33. Significant Companies of Others Table 34. Global Glucagon Drug Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Glucagon Drug Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Glucagon Drug Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Glucagon Drug Sales Volume Share by Application (2021-2026) Table 38. Global Glucagon Drug Sales Volume Share by Application (2027-2032) Table 39. Global Glucagon Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Glucagon Drug Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Glucagon Drug Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Glucagon Drug Sales Value Share by Application (2021-2026) Table 43. Global Glucagon Drug Sales Value Share by Application (2027-2032) Table 44. Global Glucagon Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Glucagon Drug Sales by Region (2021-2026) & (K Units) Table 46. Global Glucagon Drug Sales Market Share by Region (2021-2026) Table 47. Global Glucagon Drug Sales by Region (2027-2032) & (K Units) Table 48. Global Glucagon Drug Sales Market Share by Region (2027-2032) Table 49. Global Glucagon Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Glucagon Drug Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Glucagon Drug Sales Value Share by Region (2021-2026) Table 52. Global Glucagon Drug Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Glucagon Drug Sales Value Share by Region (2027-2032) Table 54. Global Glucagon Drug Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Glucagon Drug Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Glucagon Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Glucagon Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Glucagon Drug Sales by Country (2021-2026) & (K Units) Table 59. Global Glucagon Drug Sales Market Share by Country (2021-2026) Table 60. Global Glucagon Drug Sales by Country (2027-2032) & (K Units) Table 61. Global Glucagon Drug Sales Market Share by Country (2027-2032) Table 62. Global Glucagon Drug Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Glucagon Drug Sales Value Market Share by Country (2021-2026) Table 64. Global Glucagon Drug Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Glucagon Drug Sales Value Market Share by Country (2027-2032) Table 66. Eli Lilly Company Information Table 67. Eli Lilly Business Overview Table 68. Eli Lilly Glucagon Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Eli Lilly Glucagon Drug Product Portfolio Table 70. Eli Lilly Recent Development Table 71. Fresenius Kabi Company Information Table 72. Fresenius Kabi Business Overview Table 73. Fresenius Kabi Glucagon Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Fresenius Kabi Glucagon Drug Product Portfolio Table 75. Fresenius Kabi Recent Development Table 76. Torrent Labs Company Information Table 77. Torrent Labs Business Overview Table 78. Torrent Labs Glucagon Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Torrent Labs Glucagon Drug Product Portfolio Table 80. Torrent Labs Recent Development Table 81. Novo Nordisk Company Information Table 82. Novo Nordisk Business Overview Table 83. Novo Nordisk Glucagon Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Novo Nordisk Glucagon Drug Product Portfolio Table 85. Novo Nordisk Recent Development Table 86. Key Raw Materials Table 87. Raw Materials Key Suppliers Table 88. Glucagon Drug Distributors List Table 89. Glucagon Drug Customers List Table 90. Research Programs/Design for This Report Table 91. Authors List of This Report Table 92. Secondary Sources Table 93. Primary Sources List of Figures Figure 1. Glucagon Drug Product Image Figure 2. Global Glucagon Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glucagon Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Glucagon Drug Sales (2021-2032) & (K Units) Figure 5. Global Glucagon Drug Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Glucagon Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Inject Glucagon Image Figure 10. Nasal Glucagon Image Figure 11. Global Glucagon Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Glucagon Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Glucagon Drug Sales Volume Share by Type (2021-2032) Figure 14. Global Glucagon Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Glucagon Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Glucagon Drug Sales Value Share by Type (2021-2032) Figure 17. Cardiogenic Shock Image Figure 18. General Use Image Figure 19. Emergency Kits Image Figure 20. Diagnostic & Motility Image Figure 21. Others Image Figure 22. Global Glucagon Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Glucagon Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Glucagon Drug Sales Volume Share by Application (2021-2032) Figure 25. Global Glucagon Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Glucagon Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Glucagon Drug Sales Value Share by Application (2021-2032) Figure 28. Global Glucagon Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Glucagon Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Glucagon Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Glucagon Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Glucagon Drug Sales Value (2021-2032) & (US$ Million) Figure 33. North America Glucagon Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Glucagon Drug Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Glucagon Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Glucagon Drug Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Glucagon Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Glucagon Drug Sales Value (2021-2032) & (US$ Million) Figure 39. South America Glucagon Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Glucagon Drug Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Glucagon Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Glucagon Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Glucagon Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Glucagon Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Glucagon Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Glucagon Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Glucagon Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Glucagon Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Glucagon Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Glucagon Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Glucagon Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Glucagon Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Glucagon Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Glucagon Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Glucagon Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Glucagon Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Glucagon Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Glucagon Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Glucagon Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Glucagon Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Glucagon Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Glucagon Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Glucagon Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Glucagon Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Glucagon Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Glucagon Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Glucagon Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Glucagon Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Glucagon Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Glucagon Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Glucagon Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Glucagon Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Glucagon Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Glucagon Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Glucagon Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Glucagon Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Glucagon Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Glucagon Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Glucagon Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Glucagon Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Glucagon Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Glucagon Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Glucagon Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Glucagon Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Glucagon Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Glucagon Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Glucagon Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Glucagon Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Glucagon Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Glucagon Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Glucagon Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Glucagon Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Glucagon Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Glucagon Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Glucagon Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Glucagon Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Glucagon Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Glucagon Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Glucagon Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Glucagon Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Glucagon Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Glucagon Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Glucagon Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Glucagon Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Glucagon Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Glucagon Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Glucagon Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Glucagon Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Glucagon Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Glucagon Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Glucagon Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Glucagon Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Glucagon Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Glucagon Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Glucagon Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Glucagon Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Glucagon Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Glucagon Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Glucagon Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Glucagon Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Glucagon Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Glucagon Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Glucagon Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Glucagon Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Glucagon Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Glucagon Drug Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Glucagon Drug Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Inject Glucagon
  • Nasal Glucagon
Applications
  • Cardiogenic Shock
  • General Use
  • Emergency Kits
  • Diagnostic & Motility
  • Others
Companies covered
  • Eli Lilly
  • Fresenius Kabi
  • Torrent Labs
  • Novo Nordisk

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Glucagon Drug Sales Value (2021-2032)
  4. 1.2.2 Global Glucagon Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Glucagon Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Glucagon Drug Market Dynamics
  1. 2.1 Glucagon Drug Industry Trends
  2. 2.2 Glucagon Drug Industry Drivers
  3. 2.3 Glucagon Drug Industry Opportunities and Challenges
  4. 2.4 Glucagon Drug Industry Restraints
3 Glucagon Drug Market by Company
  1. 3.1 Global Glucagon Drug Company Revenue Ranking in 2025
  2. 3.2 Global Glucagon Drug Revenue by Company (2021-2026)
  3. 3.3 Global Glucagon Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Glucagon Drug Average Price by Company (2021-2026)
  5. 3.5 Global Glucagon Drug Company Ranking (2024-2026)
  6. 3.6 Global Glucagon Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Glucagon Drug Company Product Type and Application
  8. 3.8 Global Glucagon Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Glucagon Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Glucagon Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Glucagon Drug Market by Type
  1. 4.1 Glucagon Drug Type Introduction
  2. 4.1.1 Inject Glucagon
  3. 4.1.2 Nasal Glucagon
  4. 4.2 Global Glucagon Drug Sales Volume by Type
  5. 4.2.1 Global Glucagon Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Glucagon Drug Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Glucagon Drug Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Glucagon Drug Sales Value by Type
  9. 4.3.1 Global Glucagon Drug Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Glucagon Drug Sales Value by Type (2021-2032)
  11. 4.3.3 Global Glucagon Drug Sales Value Share by Type (2021-2032)
5 Glucagon Drug Market by Application
  1. 5.1 Glucagon Drug Application Introduction
  2. 5.1.1 Cardiogenic Shock
  3. 5.1.2 General Use
  4. 5.1.3 Emergency Kits
  5. 5.1.4 Diagnostic & Motility
  6. 5.1.5 Others
  7. 5.2 Global Glucagon Drug Sales Volume by Application
  8. 5.2.1 Global Glucagon Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Glucagon Drug Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Glucagon Drug Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Glucagon Drug Sales Value by Application
  12. 5.3.1 Global Glucagon Drug Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Glucagon Drug Sales Value by Application (2021-2032)
  14. 5.3.3 Global Glucagon Drug Sales Value Share by Application (2021-2032)
6 Glucagon Drug Regional Sales and Value Analysis
  1. 6.1 Global Glucagon Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Glucagon Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Glucagon Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Glucagon Drug Sales by Region (2027-2032)
  5. 6.3 Global Glucagon Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Glucagon Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Glucagon Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Glucagon Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Glucagon Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Glucagon Drug Sales Value (2021-2032)
  12. 6.6.2 North America Glucagon Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Glucagon Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Glucagon Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Glucagon Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Glucagon Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Glucagon Drug Sales Value (2021-2032)
  21. 6.9.2 South America Glucagon Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Glucagon Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Glucagon Drug Sales Value Share by Country, 2025 VS 2032
7 Glucagon Drug Country-level Sales and Value Analysis
  1. 7.1 Global Glucagon Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Glucagon Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Glucagon Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Glucagon Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Glucagon Drug Sales by Country (2027-2032)
  6. 7.4 Global Glucagon Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Glucagon Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Glucagon Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Glucagon Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Glucagon Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Glucagon Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Glucagon Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Glucagon Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Glucagon Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Glucagon Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Glucagon Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Glucagon Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Glucagon Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Glucagon Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Glucagon Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Glucagon Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Glucagon Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Glucagon Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Glucagon Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Glucagon Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Glucagon Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Glucagon Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Glucagon Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Glucagon Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Glucagon Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Glucagon Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Glucagon Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Glucagon Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Glucagon Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Glucagon Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Glucagon Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Glucagon Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Glucagon Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Glucagon Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Glucagon Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Glucagon Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Glucagon Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Glucagon Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Glucagon Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Glucagon Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Glucagon Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Glucagon Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Glucagon Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Glucagon Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Glucagon Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Glucagon Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Glucagon Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Glucagon Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Glucagon Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Glucagon Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Glucagon Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Glucagon Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Glucagon Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Glucagon Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Glucagon Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Glucagon Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Glucagon Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Glucagon Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Glucagon Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Glucagon Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Glucagon Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Glucagon Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Glucagon Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Glucagon Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Glucagon Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Glucagon Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Glucagon Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Glucagon Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Glucagon Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Glucagon Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Glucagon Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Glucagon Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Glucagon Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Glucagon Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Glucagon Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Glucagon Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Glucagon Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Glucagon Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Glucagon Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Glucagon Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Glucagon Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Glucagon Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Glucagon Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Glucagon Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Glucagon Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Glucagon Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Glucagon Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eli Lilly
  2. 8.1.1 Eli Lilly Company Information
  3. 8.1.2 Eli Lilly Business Overview
  4. 8.1.3 Eli Lilly Glucagon Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Eli Lilly Glucagon Drug Product Portfolio
  6. 8.1.5 Eli Lilly Recent Developments
  7. 8.2 Fresenius Kabi
  8. 8.2.1 Fresenius Kabi Company Information
  9. 8.2.2 Fresenius Kabi Business Overview
  10. 8.2.3 Fresenius Kabi Glucagon Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Fresenius Kabi Glucagon Drug Product Portfolio
  12. 8.2.5 Fresenius Kabi Recent Developments
  13. 8.3 Torrent Labs
  14. 8.3.1 Torrent Labs Company Information
  15. 8.3.2 Torrent Labs Business Overview
  16. 8.3.3 Torrent Labs Glucagon Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Torrent Labs Glucagon Drug Product Portfolio
  18. 8.3.5 Torrent Labs Recent Developments
  19. 8.4 Novo Nordisk
  20. 8.4.1 Novo Nordisk Company Information
  21. 8.4.2 Novo Nordisk Business Overview
  22. 8.4.3 Novo Nordisk Glucagon Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Novo Nordisk Glucagon Drug Product Portfolio
  24. 8.4.5 Novo Nordisk Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Glucagon Drug Value Chain Analysis
  2. 9.1.1 Glucagon Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Glucagon Drug Sales Mode & Process
  6. 9.2 Glucagon Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Glucagon Drug Distributors
  9. 9.2.3 Glucagon Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst